HBI Deals+Insights / M&A/IPOs
Bridgepoint is reportedly pitching to banks for an IPO of its international dialysis provider Diaverum after a failed private auction, HBI is told. We name likely second-round participants, reasons why they might have pulled out, and whether Diaverum can better the valuations of listed peers.